insights_auto
Zakaj je tečaj 600812 padel 4,72%?
Podrobneje raziščichevron_right
600812:SHA
North China Pharmaceutical Co Ltd
6,26 CN¥
arrow_downward
−4,72%(−0,31) 1D
16. okt., 15:00:00 GMT +8 · CNY
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za 600812 …
Odpri
6,33 CN¥
Visoka
6,90 CN¥
Nizka
6,10 CN¥
Povprečni promet
61,12 mio.
Promet
307,76 mio.
Dividenda
0,56 %
Četrtletna dividenda
0,01 CN¥
Prvi trgovalni dan brez upravičenja do dividende
11. jun. 2026
Razmerje med ceno delnice in čistim dobičkom
87,26
52-tedenski najvišji tečaj
6,90 CN¥
52-tedenski najnižji tečaj
4,11 CN¥
Čisti dobiček na delnico
0,07 CN¥
Št. izdanih delnic
1,63 mrd.
Št. zaposlenih
10 tis.
Odpri
6,33 CN¥
Visoka
6,90 CN¥
Nizka
6,10 CN¥
Povprečni promet
61,12 mio.
Promet
307,76 mio.
Dividenda
0,56 %
Četrtletna dividenda
0,01 CN¥
Prvi trgovalni dan brez upravičenja do dividende
11. jun. 2026
Razmerje med ceno delnice in čistim dobičkom
87,26
52-tedenski najvišji tečaj
6,90 CN¥
52-tedenski najnižji tečaj
4,11 CN¥
Čisti dobiček na delnico
0,07 CN¥
Št. izdanih delnic
1,63 mrd.
Št. zaposlenih
10 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Law360
·
pred 14 minutami
Nasdaq Sued Over Delisting Of Social Media Co.
Simply Wall Street
·
pred 5 minutami
SK Hynix (NasdaqGS:SKHY) Stock Trades At A Discount After A 22% Fall
Seeking Alpha
·
pred 14 minutami
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
MarketWatch
·
pred 4 urami
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profil
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Vizitka: North China Pharmaceutical Co Ltd
Generalni direktor-
Št. zaposlenih9,97 tis.
Ustanovljeno20. dec. 1992
Sedež-
Sektor-
Spletno mesto-